Announcement on Convening Performance Briefing for 2025 and Q1 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening Performance Briefing for 2025 and Q1 2026
Filed with SSE · · 2 pages · Chinese
Release
Zhejiang Huahai Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhejiang Huahai Pharmaceutical
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Cancellation of Account for Raised Funds
- Indicative Announcement on Convening the 2025 Annual General Meeting
- Announcement on Outline of Open Day for Investors
- Announcement on Changing Independent Directors and Adjusting Members of Special Committees of Board of Directors
Later from Zhejiang Huahai Pharmaceutical
- Announcement on Obtaining Approval for Drug Clinical Trials by Subsidiary
- Announcement on Release of Pledge and Re-pledge of Some Shares of Shareholders
- Indicative Announcement on Suspending Conversion of "Huahai Convertible Bonds" When Implementing Dividend Distribution for 2025
- Announcement on Obtaining Drug Registration Certificate
- Announcement on Implementation of Dividend Distribution for 2025
Follow Zhejiang Huahai Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Huahai Pharmaceutical